Dayli Partners
3 rounds tracked since 14 July 2025.
- Rounds
- 3
- Led
- 1
- Capital in these rounds
- $131M
Sectors
Countries
Rounds
- BreezeBioPolymer nanoparticle delivery for precision genetic medicines, formerly GenEdit $60MSeries B · 25 Feb
- GaluxLeadAI de novo protein and antibody design for drug discovery $29MSeries B · 9 Feb
- Illimis TherapeuticsDrugs for CNS and immune diseases built on its GAIA platform, led by Alzheimer's $42MSeries B · 14 Jul
No round matches these filters.